ConductScience.org, home

Trial · NCT01389856

Results by group121

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percentage of Patients With Treatment FailureBosentan7.7percentage of participants
Percentage of Patients With Treatment FailurePlacebo0percentage of participants
Time to Complete Weaning From iNOBosentan3.795% Confidence Interval 1.17 to 6.95days
Time to Complete Weaning From iNOPlacebo2.995% Confidence Interval 1.26 to 4.23days
Time to Complete Weaning From Mechanical VentilationBosentan10.895% Confidence Interval 3.21 to 12.21days
Time to Complete Weaning From Mechanical VentilationPlacebo8.695% Confidence Interval 3.71 to 9.66days
Percentage of Patients Requiring Re-initiation of iNO TherapyBosentan0percentage of participants
Percentage of Patients Requiring Re-initiation of iNO TherapyPlacebo0percentage of participants
Percentage of Patients With Pulmonary Hypertension (PH) at End of TreatmentBosentan41.7percentage of participants
Percentage of Patients With Pulmonary Hypertension (PH) at End of TreatmentPlacebo37.5percentage of participants
Change in Oxygenation Index (OI) From Baseline to 3 Hours Following Study Drug AdministrationBosentanBaseline18.395% Confidence Interval 8.2 to 35.4oxygenation index
Change in Oxygenation Index (OI) From Baseline to 3 Hours Following Study Drug AdministrationPlaceboBaseline13.295% Confidence Interval 7.9 to 39.4oxygenation index
Change in Oxygenation Index (OI) From Baseline to 3 Hours Following Study Drug AdministrationBosentan3 hours17.395% Confidence Interval 6.9 to 33.3oxygenation index
Change in Oxygenation Index (OI) From Baseline to 3 Hours Following Study Drug AdministrationPlacebo3 hours13.095% Confidence Interval 8.5 to 42.9oxygenation index
Change in Oxygenation Index (OI) From Baseline to 3 Hours Following Study Drug AdministrationBosentanChange from baseline-1.695% Confidence Interval -5.1 to 3.3oxygenation index
Change in Oxygenation Index (OI) From Baseline to 3 Hours Following Study Drug AdministrationPlaceboChange from baseline1.195% Confidence Interval -6.1 to 6.1oxygenation index
Change in Oxygenation Index (OI) From Baseline to 5 Hours Following Study Drug AdministrationBosentanBaseline18.395% Confidence Interval 8.2 to 35.4oxygenation index
Change in Oxygenation Index (OI) From Baseline to 5 Hours Following Study Drug AdministrationPlaceboBaseline13.295% Confidence Interval 7.9 to 39.4oxygenation index
Change in Oxygenation Index (OI) From Baseline to 5 Hours Following Study Drug AdministrationBosentan5 hours16.795% Confidence Interval 7.9 to 36.7oxygenation index
Change in Oxygenation Index (OI) From Baseline to 5 Hours Following Study Drug AdministrationPlacebo5 hours13.395% Confidence Interval 6.7 to 28.6oxygenation index

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01389856/results